{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:38:18Z","timestamp":1777354698757,"version":"3.51.4"},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1372,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1002\/art.30580","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T18:19:14Z","timestamp":1313000354000},"page":"3723-3732","source":"Crossref","is-referenced-by-count":128,"title":["Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors"],"prefix":"10.1002","volume":"63","author":[{"given":"Meliha Crnkic","family":"Kapetanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Roseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lennart","family":"Truedsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tore","family":"Saxne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Geborek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,11,29]]},"reference":[{"key":"10.1002\/art.30580-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccination in patients with immuno-mediated inflammatory disease","volume":"49","author":"Rahier","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30580-BIB2|cit2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3899\/jrheum.091107","article-title":"Observational studies of infections in rheumatoid arthritis: a metaanalysis of tumor necrosis factor antagonists","volume":"37","author":"Bernatsky","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3899\/jrheum.100461","article-title":"Incident comorbidity among patients with rheumatoid arthritis treated or not with low-dose glucocorticoids: a retrospective study","volume":"37","author":"Mazzantini","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB4|cit4","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.3399\/bjgp09X472629","article-title":"Identification of new risk factors for pneumonia: population-based case-control study","volume":"59","author":"Vinogradova","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1002\/art.30580-BIB5|cit5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.rdc.2009.03.009","article-title":"Infectious complications of biologic agents","volume":"35","author":"Martin-Mola","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1002\/art.30580-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/art.10529","article-title":"Predictors of infection in rheumatoid arthritis","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30580-BIB7|cit7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/03009741003674180","article-title":"Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease","volume":"39","author":"Kapetanovic","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1002\/art.30580-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1136\/ard.2008.098822","article-title":"Serious infections in patients with ankylosing spondylitis with and without TNF blockers: a systematic review and meta-analysis of randomised placebo-controlled trials","volume":"69","author":"Fouque-Aubert","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30580-BIB9|cit9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11926-010-0112-3","article-title":"Managing comorbid disease in patients with psoriatic arthritis","volume":"12","author":"Husni","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1002\/art.30580-BIB10|cit10","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1002\/art.30580-BIB11|cit11","unstructured":"1994 http:\/\/www.socialstyrelsen.se\/sosfs\/1994-26"},{"key":"10.1002\/art.30580-BIB12|cit12","first-page":"1940","article-title":"Preventive medical services among patients with rheumatoid arthritis","volume":"30","author":"Kremers","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB13|cit13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/rheumatology\/kei193","article-title":"Influence of methotrexate, TNF-blocker and prednisolone on antibody responses to pneumococcal polysacharide vaccine in patients with rheumatoid arthritis","volume":"45","author":"Kapetanovic","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30580-BIB14|cit14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/kel366","article-title":"Influenza vaccination as model for testing antibody modulation of anti-TNF and methotrexate therapy in rheumatoid arthritis patients","volume":"46","author":"Kapetanovic","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30580-BIB15|cit15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"key":"10.1002\/art.30580-BIB16|cit16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1183\/09031936.04.00063504","article-title":"Additive preventive effect of influenza and pneumococcal vaccines in elderly persons","volume":"23","author":"Christenson","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1002\/art.30580-BIB17|cit17","unstructured":"Wyeth http:\/\/www.prevenar.se"},{"key":"10.1002\/art.30580-BIB18|cit18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"10.1002\/art.30580-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1126\/science.8073278","article-title":"Pneumococcal disease: prospects for a new generation of vaccines","volume":"265","author":"Siber","year":"1994","journal-title":"Science"},{"key":"10.1002\/art.30580-BIB20|cit20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1164\/rccm.200903-0488OC","article-title":"Superior antibody response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease","volume":"180","author":"Dransfield","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/art.30580-BIB21|cit21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/323339","article-title":"Dynamics of penicillin-susceptible clones in invasive pneumococcal disease","volume":"184","author":"Henriques Normark","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30580-BIB22|cit22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30580-BIB23|cit23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/ard.61.9.793","article-title":"Etanercept, infliximab and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow-up programme in southern Sweden","volume":"61","author":"Geborek","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1002\/art.30580-BIB24|cit24","unstructured":"OnlineGCP Guideline for Good Clinical Practice http:\/\/www.onlinegcp.org Surrey (UK) Infonetica Research Solutions"},{"key":"10.1002\/art.30580-BIB25|cit25","unstructured":"World Health Organization http:\/\/www.vaccine.uab.edu\/ELISA%20Protocol.pdf"},{"key":"10.1002\/art.30580-BIB26|cit26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30580-BIB27|cit27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1002\/art.30580-BIB28|cit28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00124743-199604000-00001","article-title":"Pneumococcal vaccine in rheumatoid arthritis: decreased response while on methotrexate","volume":"2","author":"O'Dell","year":"1996","journal-title":"J Clin Rheumatol"},{"key":"10.1002\/art.30580-BIB29|cit29","first-page":"1356","article-title":"Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept","volume":"31","author":"Mease","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB30|cit30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1053\/j.semarthrit.2003.10.003","article-title":"The effect of tumour necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Elkayam","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1002\/art.30580-BIB31|cit31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1086\/338043","article-title":"Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus","volume":"34","author":"Elkayam","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1002\/art.30580-BIB32|cit32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1002\/art.30580-BIB33|cit33","first-page":"952","article-title":"Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone","volume":"34","author":"Visvanathan","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1002\/art.30580-BIB34|cit34","first-page":"272","article-title":"Antibody responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab","volume":"34","author":"Kaine","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB35|cit35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","article-title":"Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis","volume":"47","author":"Wessels","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/art.30580-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","article-title":"High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone","volume":"23","author":"Ulinski","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"10.1002\/art.30580-BIB37|cit37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/515644","article-title":"Magnitude, duration, quality, and function of pneumococcal vaccine responses in elderly adults","volume":"178","author":"Rubins","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30580-BIB38|cit38","first-page":"306","article-title":"Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus","volume":"11","author":"McDonald","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1002\/art.30580-BIB39|cit39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/649839","article-title":"Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults","volume":"201","author":"Musher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30580-BIB40|cit40","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/ije\/26.2.420","article-title":"Effect of age, sex and smoking habits on pneumococcal antibody levels in an elderly population","volume":"26","author":"Sankilampi","year":"1997","journal-title":"Int J Epidemiol"},{"key":"10.1002\/art.30580-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1002\/art.30580-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1136\/ard.2010.129908","article-title":"Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study","volume":"69","author":"Bengtsson","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.30580","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/art.30580\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T22:20:17Z","timestamp":1625091617000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.30580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,29]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1002\/art.30580","relation":{},"ISSN":["0004-3591"],"issn-type":[{"value":"0004-3591","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11,29]]}}}